TERAWULF INC (WULF)

US88080T1043 - Common Stock

2.44  -0.05 (-2.01%)

Fundamental Rating

3

Overall WULF gets a fundamental rating of 3 out of 10. We evaluated WULF against 276 industry peers in the Software industry. Both the profitability and financial health of WULF have multiple concerns. WULF shows excellent growth, but is valued quite expensive already.



1

1. Profitability

1.1 Basic Checks

In the past year WULF has reported negative net income.
In the past year WULF had a positive cash flow from operations.
In the past 5 years WULF always reported negative net income.
In the past 5 years WULF reported 4 times negative operating cash flow.

1.2 Ratios

With a Return On Assets value of -19.70%, WULF is not doing good in the industry: 67.52% of the companies in the same industry are doing better.
WULF has a Return On Equity (-33.49%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -19.7%
ROE -33.49%
ROIC N/A
ROA(3y)-28%
ROA(5y)-18.33%
ROE(3y)-62.51%
ROE(5y)-39.57%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

WULF has a Gross Margin (60.54%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of WULF has grown nicely.
The Profit Margin and Operating Margin are not available for WULF so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 60.54%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y27.64%
GM growth 5Y12.02%

2

2. Health

2.1 Basic Checks

WULF does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, WULF has more shares outstanding
Compared to 5 years ago, WULF has more shares outstanding
The debt/assets ratio for WULF has been reduced compared to a year ago.

2.2 Solvency

WULF has an Altman-Z score of 1.58. This is a bad value and indicates that WULF is not financially healthy and even has some risk of bankruptcy.
WULF has a Altman-Z score (1.58) which is comparable to the rest of the industry.
A Debt/Equity ratio of 0.00 indicates that WULF is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.00, WULF is in the better half of the industry, outperforming 72.26% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 1.58
ROIC/WACCN/A
WACC10.94%

2.3 Liquidity

WULF has a Current Ratio of 0.40. This is a bad value and indicates that WULF is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of WULF (0.40) is worse than 95.62% of its industry peers.
A Quick Ratio of 0.40 indicates that WULF may have some problems paying its short term obligations.
WULF has a worse Quick ratio (0.40) than 95.26% of its industry peers.
Industry RankSector Rank
Current Ratio 0.4
Quick Ratio 0.4

8

3. Growth

3.1 Past

WULF shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 56.63%, which is quite impressive.
Looking at the last year, WULF shows a very strong growth in Revenue. The Revenue has grown by 360.31%.
Measured over the past years, WULF shows a very strong growth in Revenue. The Revenue has been growing by 30.62% on average per year.
EPS 1Y (TTM)56.63%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q84.21%
Revenue 1Y (TTM)360.31%
Revenue growth 3Y72.74%
Revenue growth 5Y30.62%
Revenue growth Q2Q143.31%

3.2 Future

The Earnings Per Share is expected to grow by 67.56% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 78.75% on average over the next years. This is a very strong growth
EPS Next Y112.28%
EPS Next 2Y67.56%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year103.76%
Revenue Next 2Y78.75%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for WULF. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 55.21, the valuation of WULF can be described as expensive.
WULF's Price/Forward Earnings is on the same level as the industry average.
WULF is valuated expensively when we compare the Price/Forward Earnings ratio to 21.63, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 55.21

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

WULF's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as WULF's earnings are expected to grow with 67.56% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y67.56%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

WULF does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

TERAWULF INC

NASDAQ:WULF (4/26/2024, 1:49:09 PM)

2.44

-0.05 (-2.01%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap737.47M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 55.21
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -19.7%
ROE -33.49%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 60.54%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.18
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.4
Quick Ratio 0.4
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)56.63%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y112.28%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)360.31%
Revenue growth 3Y72.74%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y